文献速递贫血与红细胞疾病

携带HLA-DR15的环孢素依赖性再生障碍性贫血患者造血干祖细胞上频繁出现HLA-DR丢失

Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
PubMed 文献 · Leukemia · 2022-04-26

研究检测61例再生障碍性贫血(AA)患者外周血CD45dimCD34+CD38+细胞的HLA-DR表达,其中23例携带HLA-I类等位基因缺失白细胞。7例(11.5%)HLA-DR15阳性且无HLA-I类缺失白细胞的患者中,DR(-)细胞占造血干祖细胞(HSPC)总量的13.0-57.1%。分选的DR(-) HSPC经IFN-γ孵育72小时后DR表达完全恢复。DR(-)与DR(+) HSPC转录组比较显示DR(-)细胞免疫应答相关基因(包括共刺激分子CD48、CD74、CD86)表达较低,而HLA-I类缺失HSPC中未见此现象。4例可分别分析GPI(+)和GPI(-) HSPC的患者中,DR(-)细胞仅见于GPI(+) HSPC。提示HSPC上HLA-DR15呈递抗原所特异的CD4+ T细胞可能参与AA发病,并以不同于CD8+ T细胞识别HLA-I类限制性抗原的方式参与GPI(-) HSPC的免疫逃逸。

要点

  • 7例(11.5%)HLA-DR15阳性且无HLA-I类缺失白细胞的AA患者中,DR(-)细胞占HSPC总量的13.0-57.1%。
  • 分选DR(-) HSPC经IFN-γ孵育72小时后DR表达完全恢复。
  • DR(-)细胞中免疫应答相关基因包括CD48、CD74、CD86表达较低,HLA-I类缺失HSPC中未见此现象。

核心结论

  • HSPC上HLA-DR15呈递的抗原所特异的CD4+ T细胞可能参与AA发病,并以不同于CD8+ T细胞识别HLA-I类限制性抗原的方式参与GPI(-) HSPC的免疫逃逸。

研究设计与样本

  • 研究61例AA患者外周血CD45dimCD34+CD38+细胞的HLA-DR表达,其中23例携带HLA-I类等位基因缺失白细胞。

主要发现

  • 7例(11.5%)HLA-DR15阳性且无HLA-I类缺失白细胞的患者中,DR(-)细胞占HSPC总量的13.0-57.1%。
  • 分选DR(-) HSPC在IFN-γ存在下孵育72小时导致DR表达完全恢复。
  • DR(-)与DR(+) HSPC转录组比较显示DR(-)细胞免疫应答相关基因包括共刺激分子CD48、CD74、CD86表达较低,HLA-I类缺失HSPC中未见此现象。
  • 4例可分别分析GPI(+)和GPI(-) HSPC的患者中,DR(-)细胞仅见于GPI(+) HSPC。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To determine whether antigen presentation by HLA-DR on hematopoietic stem progenitor cells (HSPCs) is involved in the development of acquired aplastic anemia (AA), we studied the HLA-DR expression on CD45dimCD34+CD38+ cells in the peripheral blood of 61 AA patients including 23 patients possessing HLA-class I allele-lacking (HLA-class I[-]) leukocytes. HLA-DR-lacking (DR[-]) cells accounted for 13.0-57.1% of the total HSPCs in seven (11.5%) patients with HLA-DR15 who did not possess HLA-class I(-) leukocytes. The incubation of sorted DR(-) HSPCs in the presence of IFN-γ for 72 h resulted in the full restoration of the DR expression. A comparison of the transcriptome profile between DR(-) and DR(+) HSPCs revealed the lower expression of immune response-related genes including co-stimulatory molecules (e.g., CD48, CD74, and CD86) in DR(-) cells, which was not evident in HLA-class I(-) HSPCs. DR(-) cells were exclusively detected in GPI(+) HSPCs in four patients whose HSPCs could be analyzed separately for GPI(+) and GPI(-) HSPCs. These findings suggest that CD4+ T cells specific to antigens presented by HLA-DR15 on HSPCs may contribute to the development of AA as well as the immune escape of GPI(-) HSPCs in a distinct way from CD8+ T cells recognizing HLA-class I-restricted antigens.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Tsuji N, Hosokawa K, Urushihara R, et al. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15. Leukemia. 2022. PMID: 35474098. doi:10.1038/s41375-022-01549-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。